Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Marchand

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Molecules (Basel, Switzerland)|October 17, 2019
Discovery of Novel Integrase Inhibitors Acting outside the Active Site Through High-Throughput ScreeningCindy Aknin, Elena A Smith, Christophe Marchand, et al.
Bioorganic & Medicinal Chemistry|July 24, 2018
Corrigendum to “Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores” [Bioorg. Med. Chem. 18 (2010) 182–189]Iwona E Weidlich, Thomas Dexheimer, Christophe Marchand, et al.
Biochemistry|August 16, 2008
Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutantsJessica Marinello, Christophe Marchand, Bryan T Mott, et al.
Bioorganic & Medicinal Chemistry|December 8, 2009
Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophoresIwona E Weidlich, Thomas Dexheimer, Christophe Marchand, et al.
Proteomics|September 8, 2004
New targets of Arabidopsis thioredoxins revealed by proteomic analysisChristophe Marchand, Pierre Le Maréchal, Yves Meyer, et al.
European Journal of Biochemistry|August 20, 2004
Thioredoxin Ch1 of Chlamydomonas reinhardtii displays an unusual resistance toward one-electron oxidationCécile Sicard-Roselli, Stéphane Lemaire, Jean-Pierre Jacquot, et al.
Journal of Medicinal Chemistry|April 21, 2016
Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400)Peng-Cheng Lv, Mohamed S A Elsayed, Keli Agama, et al.
DNA Repair|May 27, 2014
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)Yves Pommier, Shar-yin N Huang, Rui Gao, et al.
Bioorganic & Medicinal Chemistry|July 21, 2018
Virtual screening using ligand-based pharmacophores for inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1)Iwona E Weidlich, Thomas S Dexheimer, Christophe Marchand, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
Functional evidence for active site location of tetrameric thymidylate synthase X at the interphase of three monomersDamien Leduc, Sébastien Graziani, Gerard Lipowski, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Molecules (Basel, Switzerland)|October 17, 2019
Discovery of Novel Integrase Inhibitors Acting outside the Active Site Through High-Throughput ScreeningCindy Aknin, Elena A Smith, Christophe Marchand, et al.
Bioorganic & Medicinal Chemistry|July 24, 2018
Corrigendum to “Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores” [Bioorg. Med. Chem. 18 (2010) 182–189]Iwona E Weidlich, Thomas Dexheimer, Christophe Marchand, et al.
Biochemistry|August 16, 2008
Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutantsJessica Marinello, Christophe Marchand, Bryan T Mott, et al.
Bioorganic & Medicinal Chemistry|December 8, 2009
Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophoresIwona E Weidlich, Thomas Dexheimer, Christophe Marchand, et al.
Proteomics|September 8, 2004
New targets of Arabidopsis thioredoxins revealed by proteomic analysisChristophe Marchand, Pierre Le Maréchal, Yves Meyer, et al.
European Journal of Biochemistry|August 20, 2004
Thioredoxin Ch1 of Chlamydomonas reinhardtii displays an unusual resistance toward one-electron oxidationCécile Sicard-Roselli, Stéphane Lemaire, Jean-Pierre Jacquot, et al.
Journal of Medicinal Chemistry|April 21, 2016
Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400)Peng-Cheng Lv, Mohamed S A Elsayed, Keli Agama, et al.
DNA Repair|May 27, 2014
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)Yves Pommier, Shar-yin N Huang, Rui Gao, et al.
Bioorganic & Medicinal Chemistry|July 21, 2018
Virtual screening using ligand-based pharmacophores for inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1)Iwona E Weidlich, Thomas S Dexheimer, Christophe Marchand, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
Functional evidence for active site location of tetrameric thymidylate synthase X at the interphase of three monomersDamien Leduc, Sébastien Graziani, Gerard Lipowski, et al.
Pageof 11